Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · American Pension Investors

Yorktown Small-cap Fund Class A (YOVAX)

Ticker YOVAX · Since 2016-05-09 · · Holdings as of Jul 31, 2026

Expense ratio
1.6%$160/yr per $10k
5-yr return
+2.9%annualized
1-yr return
+3.1%as of Dec 2025
Net assets
$36.0Mall share classes
Holdings
93

Bottom line

Is YOVAX a good fund? The bottom line

YOVAX is the Class A share class of Yorktown Small-cap Fund, a managed small-cap mutual fund from American Pension Investors.

Annual fees run 1.6% — about $160 a year on every $10,000 invested, more expensive than 88% of small-cap funds we track.

It returned +3.1% over one year, +2.9% a year over five years (as of Dec 31, 2025, per its prospectus).

With $36.0 million in net assets and 93 holdings, its largest position is Guardant Health Inc (4.0%) and the top 10 make up 21.6% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • Expensive for its category (1.6%)
  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($36.0 million) — small funds are likelier to close

Updated Nov 19, 2026

What YOVAX invests in

Investment Objective The Fund seeks to achieve long term capital appreciation.

The Fund seeks to achieve its investment objective by investing in U.S. listed securities with market capitalization within the range of the targeted benchmark, the Russell 2000 Total Return Index. Under normal circumstances, the Fund invests at least 80% of its assets (plus the amount of any borrowings for investment purposes) in small cap companies. At any given time, the Fund may hold up to 15% of its assets in American Depositary Receipts. Typically, the Fund invests in approximately 50-200 stocks that pass the Advisers stringent quantitative and fundamental criteria. The Fund's investments in any one sector may exceed 25% of its net assets. As of February 28, 2026, over 25% of the Funds assets were invested in securities within the technology sector. The Adviser believes that the Fund is best able to achieve long-term capital appreciation through investments in securities of a…

From the fund's prospectus (filed May 27, 2026).

YOVAX performance

Average annual total returns
1 yr5 yr10 yr
YOVAX+3.1%+2.9%—
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full YOVAX performance history →

What YOVAX costs

On a $10,000 investment, YOVAX's 1.6% expense ratio costs about $160 a year. The prospectus estimates $2,756 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full YOVAX fee table →

YOVAX top 10 holdings

#Holding% of fund
1Guardant Health Inc3.98%
2Acm Research Inc2.90%
3Chefs' Warehouse Inc (the)2.26%
4Ies Holdings Inc1.94%
5Palo Alto Networks Inc1.93%
6Ionq Inc1.89%
7Dave Inc1.81%
8Axos Financial Inc1.69%
9Mirum Pharmaceuticals Inc1.65%
10Enova International Inc1.59%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 21.6% of the fund. See all top 25 holdings and asset mix →

Alternatives to YOVAX

More funds like YOVAX →

YOVAX FAQ

What is the expense ratio of YOVAX?
YOVAX's expense ratio is 1.6%, which works out to about $160 a year for every $10,000 invested. The prospectus estimates total costs of $2,756 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is YOVAX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.6%); 5-year return in the bottom quarter of its category; front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year; small fund ($36.0 million) — small funds are likelier to close. This is general information, not personalized advice.
What does YOVAX hold?
YOVAX's largest holdings are Guardant Health Inc (4.0%), Acm Research Inc (2.9%), Chefs' Warehouse Inc (the) (2.3%), Ies Holdings Inc (1.9%), Palo Alto Networks Inc (1.9%). It holds 93 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is YOVAX's 5-year return?
YOVAX returned +2.9% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Does YOVAX have a sales load?
Yes. YOVAX has a maximum front-end sales charge of 5.75%. It may charge a deferred sales charge of up to 0.5% if sold early.
Who manages YOVAX?
YOVAX is offered by American Pension Investors through American Pension Investors Trust.